HopeStage
Back to all studies
WithdrawnNCT01015066

Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents

Medication studyAges 16–25United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 16 years to 25 years.

Listed locations
BuffaloSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateNovember 2009
Recruitment status
Withdrawn
Enrollment listed in the registry
0
Sponsor
State University of New York at Buffalo
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States
Age range
From 16 Years to 25 Years
Official registry ID
NCT01015066
Official title
Show the full official title

A Randomized Controlled Trial Comparing Buprenorphine/Naloxone With Naltrexone for Treatment in Opioid Dependent Adolescents and Young Adults

Recruitment & locations

Withdrawn

Buffalo

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is State University of New York at Buffalo, a university.

Does this study involve medication?

Yes. The study involves medication, including Buprenorphine/naloxone and Naltrexone.

Who can participate?

Listed age limits: 16 years to 25 years.

Is this study still recruiting?

The registry lists this study as withdrawn.

Want to explore more studies?

Explore studies